DaVita (DVA) SEC Filings: History & Chart

DaVita Inc. (DVA)DVADaVita Inc.

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO

78,000 employees

www.davita.com

Healthcare / Medical - Care Facilities

Sector: Healthcare
Industry: Medical - Care Facilities
CEO: Javier J. Rodriguez

View full financials

Form	Filing Date	Accepted	Document
4	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
11-K	Jun 17, 2026	Jun 17, 2026	View filing
8-K	Jun 8, 2026	Jun 8, 2026	View filing
4	May 28, 2026	May 28, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 13, 2026	May 13, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 8, 2026	May 8, 2026	View filing
4	May 5, 2026	May 5, 2026	View filing
10-Q	May 5, 2026	May 5, 2026	View filing
8-K	May 5, 2026	May 5, 2026	View filing
ARS	Apr 22, 2026	Apr 22, 2026	View filing
DEFA14A	Apr 22, 2026	Apr 22, 2026	View filing
DEF 14A	Apr 22, 2026	Apr 22, 2026	View filing
SC 13G/A	Mar 26, 2026	Mar 26, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing
4	Mar 17, 2026	Mar 17, 2026	View filing

SEC Filings

Recent Filings